
pmid: 6862492
Stochastic adaptive controllers have been developed for automatic control of blood pressure during infusions of cardiostimulatory or vasoactive drugs. An adaptive algorithm based upon a minimum variance control law is presented. A more advanced algorithm obtained by augmenting the performance measure to include the rate of charge of the control signal is also presented. An autoregressive-moving-average (ARMA) model, representing the dynamics of the system, and a recursive least-squares parameter estimation technique are used for both algorithms. A series of experiments was performed in dogs, utilizing an electronically activated drug infuser. Stable control was achieved, even when the circulatory state of the animal underwent major changes, using either algorithm. On the basis of theoretical considerations and experimental results, we expect that these adaptive controllers will significantly improve the performance of drug infusion systems in clinical applications.
Male, Computers, Models, Cardiovascular, Animals, Infusions, Intra-Arterial, Blood Pressure, Infusions, Parenteral, Feedback
Male, Computers, Models, Cardiovascular, Animals, Infusions, Intra-Arterial, Blood Pressure, Infusions, Parenteral, Feedback
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 88 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
